BML Capital Management, LLC 13F holdings
BML Capital Management, LLC reported 15 positions with a total reported value of $175.1M as of 2026-06-30, in its 13F for Q2 2026, filed 2026-08-07. Top holdings by reported value: ACRS ACLARIS THERAPEUTICS INC (36.2%), AVIR ATEA PHARMACEUTICALS INC (18.5%), ENGN ENGENE THERAPEUTICS INC (6.6%), KHC KRAFT HEINZ CO (6.3%), OM OUTSET MED INC (6.2%). Against 2026-03-31 it opened 1 new position and exited 1. Next 13F due by 2026-11-14, the legal deadline 45 days after the quarter ending 2026-09-30.
Email me when BML Capital Management, LLC files its 13F
A free account follows up to 10 funds. New 13F filings arrive in your daily or weekly digest. No password and no card.
Top holdings
15 largest of 15 positions · reported value as of 2026-06-30
| Holding | Shares | Reported value | % of portfolio |
|---|---|---|---|
| ACRS ACLARIS THERAPEUTICS INC | 11,975,000 | $63.3M | 36.2% |
| AVIR ATEA PHARMACEUTICALS INC | 6,952,330 | $32.3M | 18.5% |
| ENGN ENGENE THERAPEUTICS INC | 6,669,908 | $11.5M | 6.6% |
| KHC KRAFT HEINZ CO | 465,000 | $11.0M | 6.3% |
| OM OUTSET MED INC | 2,519,701 | $10.9M | 6.2% |
| KMX CARMAX INC | 172,500 | $9.1M | 5.2% |
| TLYS TILLYS INC | 2,150,000 | $9.0M | 5.2% |
| PMVP PMV PHARMACEUTICALS INC | 5,330,000 | $7.1M | 4.1% |
| TIL INSTIL BIO INC | 645,600 | $5.0M | 2.8% |
| TGT TARGET CORP | 37,500 | $4.9M | 2.8% |
| ORMP ORAMED PHARMACEUTICALS INC | 866,269 | $4.2M | 2.4% |
| JANX JANUX THERAPEUTICS INC | 154,961 | $2.4M | 1.4% |
| PLRX PLIANT THERAPEUTICS INC | 1,546,137 | $1.8M | 1.0% |
| CNTB CONNECT BIOPHARMA HLDGS LTD | 573,287 | $1.4M | 0.8% |
| IMA IMAGENEBIO INC | 200,730 | $1.2M | 0.7% |
SEC FORM 13F · Q2 2026 · VALUES AS REPORTED, NOT PRICES
New positions this quarter
Held at 2026-06-30, not at 2026-03-31 · 1 in all · reported value as of 2026-06-30
| Holding | Shares | Reported value | % of portfolio |
|---|---|---|---|
| ENGN ENGENE THERAPEUTICS INC | 6,669,908 | $11.5M | 6.6% |
Sold out
Held at 2026-03-31, gone by 2026-06-30 · 1 in all · reported value as of 2026-03-31
| Holding | Shares 2026-03-31 | Reported value | % of portfolio then |
|---|---|---|---|
| KEZAR LIFE SCIENCES INC | 720,787 | $5.3M | 3.4% |
Biggest increases and decreases
Positions held at both quarter ends, by change in shares · reported value as of 2026-06-30
Increases
| Holding | Shares 2026-03-31 | Shares 2026-06-30 | Change | Reported value |
|---|---|---|---|---|
| KHC KRAFT HEINZ CO | 125,000 | 465,000 | +272.0% | $11.0M |
| OM OUTSET MED INC | 1,902,201 | 2,519,701 | +32.5% | $10.9M |
| KMX CARMAX INC | 155,000 | 172,500 | +11.3% | $9.1M |
| CNTB CONNECT BIOPHARMA HLDGS LTD | 408,887 | 573,287 | +40.2% | $1.4M |
| PMVP PMV PHARMACEUTICALS INC | 5,320,000 | 5,330,000 | +0.2% | $7.1M |
Decreases
| Holding | Shares 2026-03-31 | Shares 2026-06-30 | Change | Reported value |
|---|---|---|---|---|
| ACRS ACLARIS THERAPEUTICS INC | 14,250,000 | 11,975,000 | -16.0% | $63.3M |
| ORMP ORAMED PHARMACEUTICALS INC | 3,167,231 | 866,269 | -72.6% | $4.2M |
| AVIR ATEA PHARMACEUTICALS INC | 7,058,657 | 6,952,330 | -1.5% | $32.3M |
CIK 1616824 · 13F FILINGS ON EDGAR · INFORMATIONAL ONLY
